Sixten Harborg, MD
@sixtenharborg.bsky.social
Currently📍Visiting Research Scholar in the Eliassen lab @harvardHSPH @harvardHMS @MGB 🇺🇸 | PhD fellow in clinical oncology @oncaarhus @AUHdk @AarhusUni | Researches breast cancer | 🇸🇪 lost in 🇩🇰
Previously •Breast Cancer Research Updates• @X
Previously •Breast Cancer Research Updates• @X
The molecular changes affecting breast cancer progression in women with metabolic syndrome are complex
January 8, 2025 at 2:32 PM
The molecular changes affecting breast cancer progression in women with metabolic syndrome are complex
Beautifully depicted work on obesity and risk of distant recurrence in BC pts by EBCTCG👏🏻
Across data from 147 including 200.000+ pts they demonstrated that BMI is independently associated with risk of distant recurrence regardless of treatment characteristics📈
@sabcs.bsky.social
Across data from 147 including 200.000+ pts they demonstrated that BMI is independently associated with risk of distant recurrence regardless of treatment characteristics📈
@sabcs.bsky.social
December 12, 2024 at 6:32 PM
Beautifully depicted work on obesity and risk of distant recurrence in BC pts by EBCTCG👏🏻
Across data from 147 including 200.000+ pts they demonstrated that BMI is independently associated with risk of distant recurrence regardless of treatment characteristics📈
@sabcs.bsky.social
Across data from 147 including 200.000+ pts they demonstrated that BMI is independently associated with risk of distant recurrence regardless of treatment characteristics📈
@sabcs.bsky.social
A great start to @sabcs.bsky.social day 3 with a session on survivorship.
Intriguing data on GLP-1ra’s in adjuvant BC care❗️ As suspected by many GLP1ra’s seems to be less effective in pts treated with ET…
Brilliantly discussed by @neil-iyengarmd.bsky.social 👏🏻
Intriguing data on GLP-1ra’s in adjuvant BC care❗️ As suspected by many GLP1ra’s seems to be less effective in pts treated with ET…
Brilliantly discussed by @neil-iyengarmd.bsky.social 👏🏻
December 12, 2024 at 4:18 PM
A great start to @sabcs.bsky.social day 3 with a session on survivorship.
Intriguing data on GLP-1ra’s in adjuvant BC care❗️ As suspected by many GLP1ra’s seems to be less effective in pts treated with ET…
Brilliantly discussed by @neil-iyengarmd.bsky.social 👏🏻
Intriguing data on GLP-1ra’s in adjuvant BC care❗️ As suspected by many GLP1ra’s seems to be less effective in pts treated with ET…
Brilliantly discussed by @neil-iyengarmd.bsky.social 👏🏻
Happy to be @sabcs.bsky.social and share the results from our study on the risk of CVD events and CVD mortality in BC patients with type 2 diabetes 🫀📈
Thankful to @graspcancer.bsky.social for awarding our poster with the GRASP Advocate Choice Award🏅
If you are at #SABCS24 and would like to chat⬇️
Thankful to @graspcancer.bsky.social for awarding our poster with the GRASP Advocate Choice Award🏅
If you are at #SABCS24 and would like to chat⬇️
December 12, 2024 at 4:19 AM
Happy to be @sabcs.bsky.social and share the results from our study on the risk of CVD events and CVD mortality in BC patients with type 2 diabetes 🫀📈
Thankful to @graspcancer.bsky.social for awarding our poster with the GRASP Advocate Choice Award🏅
If you are at #SABCS24 and would like to chat⬇️
Thankful to @graspcancer.bsky.social for awarding our poster with the GRASP Advocate Choice Award🏅
If you are at #SABCS24 and would like to chat⬇️